Latest filing published 02 Mar 2018 for GlaxoSmithKline plc, €636k.
Insider track record
P Vallance: trading record in brief
P Vallance appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). Over a trading history stretching from 15 February 2018 to 1 March 2018, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 2 March 2018 came the latest disclosure, a share grant for €636k in GlaxoSmithKline plc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to P Vallance
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,111 shares@ £13.07255.4% of flown/aISIN GB0009252882FCA-NSM:LSE20180302131115_13553137_20200330111428047_28817-12
- 34,344 sharesn/aISIN GB0009252882FCA-NSM:LSE20180220131548_13539578_20200330111412460_8832-14
- 34,344 shares@ £13.17644.6% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180220131548_13539578_20200330111412460_8832-15
- 34,344 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180216172944_13536899_20200330111412573_11179-7
- 156,984 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180216172538_13536896_20200330111412573_11182-10
5 of 5 declarations